Meet the Innovators Shaping the Future of ADC Toxicity Take a look at the esteemed speaker faculty for the 4th ADC Toxicity Summit. Pharma Biotech Academia Chair Pharma Oluwadamilola Ogunyankin Senior Medical DirectorAbbvie Zenta Tsuchihashi Head Senior Director, Translational Safety, Clinical Safety & PharmacovigilanceDaiichi Sankyo Kazuyoshi Kumagai Senior DirectorDaiichi Sankyo Kwasi Amofa Scientist Translational DMPK SciencesJohnson & Johnson Ganesh Swaminathan Principal ScientistPfizer Philip Moquist Director in ADC ChemistryPfizer Biotech Rakesh Dixit President & Chief Executive OfficerBionavigen Jutta Deckert Vice President, Research & DevelopmentIksuda Therapeutics Rodrigo Ruiz-Soto Chief Medical OfficerLigaChem Biosciences Michael Weickert Chief Executive OfficerPacylex Pharmaceuticals, Inc. Doo Young Jung Founder & Chief Executive OfficerPinot Bio, Inc. Christian Marsolais Senior Vice President & Chief Medical OfficerTheratechnologies Academia Meabh O’Hare Fellow of NeurologyBrigham and Women's Hospital Elad Sharon Director of Clinical, Translational & Immunotherapy Toxicity ProgramDana-Farber Cancer Institute Jae You Instructor in OphthalmologyHarvard Medical School Chair Mauricio Garcia-Atance Program DirectorHanson Wade Explore the Agenda Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions. View Presentations & Speakers Partner With Us Showcase your toxicology, translational, and safety solutions directly to ADC leaders actively seeking partners to de-risk clinical development. Explore Sponsorship Options Join Biopharma Experts Connect with toxicologists, translational scientists, clinicians, and pharmacologists shaping the future of safer, more tolerable ADCs. Register Now